Elevated circulating CHI3L1 levels are associated with hypertension in obstructive sleep apnea patients and cirrhotic portal hypertension (CPH), indicating the potential of CHI3L1 as a specific biomarker for hypertension155,160. This evidence concerns the gene CHI3L1 and portal hypertension.